These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4601078)

  • 21. Cerebrovascular disease.
    Warlow CP
    Clin Haematol; 1981 Jun; 10(2):631-51. PubMed ID: 7032789
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clopidogrel protection is not increased further by ASS!].
    Bogousslavsky J
    Praxis (Bern 1994); 2004 Aug; 93(35):1390. PubMed ID: 15468578
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulfinpyrazone and platelet function in hypertensive patients.
    Davi G; Novo S; Gullotti D; Avellone G; Sofia MA; Strano A
    Thromb Haemost; 1984 Jul; 51(3):413. PubMed ID: 6388015
    [No Abstract]   [Full Text] [Related]  

  • 24. Bilateral and simultaneous amaurosis fugax.
    Pejic R
    J Indiana State Med Assoc; 1982 Jun; 75(6):396-7. PubMed ID: 7097020
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
    J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
    Guiraud-Chaumeil B; Rascol A; David J; Boneu B; Clanet M; Bierme R
    Rev Neurol (Paris); 1982; 138(5):367-85. PubMed ID: 6815756
    [No Abstract]   [Full Text] [Related]  

  • 27. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of cardiac hemolytic anemia by sulfinpyrazone therapy.
    Owen J; Seidenfeld AM; Glynn MF
    Can Med Assoc J; 1980 Mar; 122(5):554-6. PubMed ID: 7370859
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomized trial of therapy with platelet antiaggregants for threatened stroke. 2: Observations on the pathogenesis and natural history of threatened stroke.
    Barnett HJ; Gent M; Sackett DL; Taylor DW
    Can Med Assoc J; 1980 Mar; 122(5):535-40. PubMed ID: 6989464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The changing indications for carotid endarterectomy in the UK.
    Panayiotopoulos YP; Padayachee S; Colchester AC; Taylor PR
    Int J Clin Pract; 1997 Sep; 51(6):375-7. PubMed ID: 9489066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Platelets and coronary artery disease (CAD) (author's transl)].
    Reimers HJ; Misera R; Schneider W; Loogen F
    Z Kardiol; 1980 Dec; 69(12):799-814. PubMed ID: 7025482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
    Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis of amaurosis fugax].
    Terao S; Mitsuma T; Takeda A; Ishikawa S; Itoh E
    Nihon Rinsho; 1993 Nov; 51 Suppl():942-7. PubMed ID: 8283779
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
    Haas S; Ketterl R; Blümel G
    Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The platelet inhibitor problem].
    Straub PW
    Schweiz Med Wochenschr; 1981 Apr; 111(14):478-82. PubMed ID: 7015489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [After TIA and stroke: a statin for secondary prevention?].
    MMW Fortschr Med; 2006 Jun; 148(24):10. PubMed ID: 16850798
    [No Abstract]   [Full Text] [Related]  

  • 37. [3GS prevention and therapy of transient cerebral ischemic attacks in the aged].
    Mancini M; Dall'Asta D; Maini C; Cucinotta D
    G Clin Med; 1983; 64(1-2):51-65. PubMed ID: 6345252
    [No Abstract]   [Full Text] [Related]  

  • 38. Of platelets, their antagonists, and transient cerebral ischemia.
    Dalessio DJ
    JAMA; 1978 Jan; 239(3):228-9. PubMed ID: 338935
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacology and pharmacokinetics of platelet-active drugs under current clinical investigation.
    FitzGerald GA; Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():107-72. PubMed ID: 6216780
    [No Abstract]   [Full Text] [Related]  

  • 40. Demonstration of pathological circulating endothelial cells in patients with amaurosis fugax.
    Bardy M
    Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):385-7. PubMed ID: 6946628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.